USPTO serial 79317950
ESB
Reviewed by CopyMark Law Group
Reg. 6868337Status 404
- Filing date
- Status date
- Registration date
- Oct 11, 2022
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ESB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lauren K. Tagarao
Lauren K. Tagarao Renner, Otto, Boisselle & Sklar, LLP1621 Euclid Ave, 19th FloorCleveland, OH 44115UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals; nucleic acid reagents for scientific or medical research use, other than for medical purposes; nucleic acid sequences, other than for medical or veterinary purposes; nucleic acids for scientific purposes, namely nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification | SECTION 70 - CANCELLED | — |
| 005 | Nucleic acid sequences for medical and veterinary purposes; nucleic acid medicines, namely, nucleic acid sequences for medical and veterinary purposes; pharmaceutical drugs, namely, pharmaceutical preparations for the treatment of infectious diseases, respiratory diseases, and cancers | SECTION 70 - CANCELLED | — |
| 040 | Custom manufacture of pharmaceuticals | SECTION 70 - CANCELLED | — |
| 042 | Development of pharmaceutical preparations and medicines; research in the field of pharmaceuticals; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; consultancy in the field of pharmaceutical research; providing information about medical research in the field of pharmaceuticals | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BONAC CORPORATION
- Other trademarks owned by BONAC CORPORATION
- Other trademarks owned by BONAC CORPORATION
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ESB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 6, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 6, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 20, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 30, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 30, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 11, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 11, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 11, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 26, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 26, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 25, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 6, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 6, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 6, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 20, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 20, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 1, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 1, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 11, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 24, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 20, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 19, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 12, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |